BGG astaxanthin patent expands heart health, healthy aging applications

By Hank Schultz

- Last updated on GMT

BGG says it is expanding the capacity of its closed tube algae production facility in Yunnan Province in southwestern China. BGG photo.
BGG says it is expanding the capacity of its closed tube algae production facility in Yunnan Province in southwestern China. BGG photo.

Related tags Astaxanthin cardiovascular health healthy aging

Astaxanthin supplier BGG has announced a new patent that further expands the carotenoid’s applications in cardiovascular health and healthy aging.

The US patent No. 10,827,775 was issued in November and covers the use of astaxanthin to support heart function during exercise.  The company says the patent will have potential for both cardiovascular health for athletes as well as active nutrition consumers.

Astaxanthin has shown intriguing cardiovascular effects in research for some time.  A widely reported 2011 study showed that the carotenoid, which is most commonly extracted from the Haematococcus pluvialis algae species, boosted cycling time trial performance​.

Study showed astaxanthin boosted cardiovascular efficiency

BGG supported its patent application with a study the company conducted on runners which was published in the open access journal ECronicon​ in 2017.  This study found that the carotenoid boosted performance amount a cohort of 28 recreational runners at lower intensities.  In particular, the group that was supplemented with 12 mg of astaxanthin for 8 weeks achieved the same output as the placebo group but at lower heart rates.

“The subjects in this study were able to perform the same amount of ‘work’—but at lower cardiovascular ‘strain’ after supplementing with Astaxanthin,​” said Dr. Shaw Talbott, PhD, one of the study’s authors.  Talbott said astaxanthin’s apparent ability to boost cardiovascular efficiency suggests further research avenues in support individuals already suffering from cardiovascular disease or elderly individuals experience lower cardiovascular output as a normal consequence of aging.

“BGG focuses on innovation by dedicating 5% of gross revenue to R&D.  As a prime example of this policy, we are one of only a very small handful of Astaxanthin producers sponsoring clinical research to validate our product, and have published several Astaxanthin clinical studies over the last few years.  This patent is another example of how BGG supports our customers through our investment in research and constant innovation; we’ve successfully opened up a whole new area of health benefits for our Astaxanthin customers to focus on,” said Yanmei Li, PhD, l​ead inventor of the US patent and BGG’s global chief scientific officer.

Expanding capacity

BGG, through its algae production subsidiary Algae Health Science, has been expanding its production capacity​ at its facility in Yunnan Province in southwestern China.  The first phase of the expansion was slated to have been complete in fall of 2020, though there is no information on how the pandemic affected those plans.  When the rest of the expansion of the closed tube facility is completed this year the company says its production capacity will have more than doubled.

Source:​ ECronicon
Published: November 06, 2017
Effect of Astaxanthin Supplementation on Cardiorespiratory Function in Runners
Authors: Talbott S, et al.

Related news

Show more

Related products

show more

A Taste of Metabolic Health

A Taste of Metabolic Health

ADM | 21-Mar-2023 | Case Study

Are you ready to transform the way consumers support their metabolic health? Our latest case study featuring ADM’s propriety, awarding winning strain Bifidobacterium...

Standard-Form & Functionally Optimized Nutrients

Standard-Form & Functionally Optimized Nutrients

Glanbia Nutritionals | 09-Mar-2023 | Product Brochure

Whether you’re looking to source the standard form of a nutrient or need a version that performs at its best in your product application, we have a robust...

Related suppliers

Follow us

Featured Events

View more


View more